Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Medisys on its merger with Cityzen Bryan, Garnier & Co acts as Sole Financial Advisor to Metsys on its growth financing led by European Digital Group Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Basilea Pharmaceutica on its CHF 46 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Ginolis Ltd on the sale of the company to BICO AB Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Radon Creative to Valtech Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to MedinCell on its EUR 30 million Follow-on Offering
